Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.280 | 2 | 111039881 | intron variant | A/G | snv | 0.15 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.830 | 1.000 | 5 | 2008 | 2013 | |||||||
|
0.925 | 0.120 | 2 | 110858527 | intron variant | G/A | snv | 0.19 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 2 | 111114320 | non coding transcript exon variant | G/A | snv | 0.42 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.160 | 2 | 110842129 | intron variant | G/A | snv | 0.44 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 2 | 110850255 | intron variant | A/G | snv | 0.38 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.280 | 2 | 111039881 | intron variant | A/G | snv | 0.15 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 3 | 2008 | 2013 | |||||||
|
0.925 | 0.120 | 2 | 111074216 | intron variant | T/C | snv | 0.13 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||||
|
0.925 | 0.120 | 2 | 111074216 | intron variant | T/C | snv | 0.13 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||||
|
2 | 110852366 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
2 | 110852366 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
2 | 110852366 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
2 | 111092082 | intron variant | A/G | snv | 0.48 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
2 | 111092082 | intron variant | A/G | snv | 0.48 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
2 | 110843901 | intron variant | G/A | snv | 0.36 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
2 | 111049969 | intron variant | G/C | snv | 5.0E-03 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 2 | 110841146 | intron variant | A/G | snv | 1.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 2 | 110842942 | intron variant | C/T | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 2 | 110842942 | intron variant | C/T | snv | 0.18 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 2 | 110858527 | intron variant | G/A | snv | 0.19 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
2 | 110937220 | intron variant | G/C | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
2 | 110995154 | intron variant | T/G | snv | 3.3E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 |